These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3081396)

  • 1. Monoamine oxidase: an important intracellular regulator of gastrin release in the rat.
    Dial EJ; Huang J; Delansorne R; Lichtenberger LM
    Gastroenterology; 1986 Apr; 90(4):1018-23. PubMed ID: 3081396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle.
    Hovevey-Sion D; Finberg JP
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):70-6. PubMed ID: 3114651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selective monoamine oxidase A and B inhibitors on footshock induced aggression in paired rats.
    Datla KP; Bhattacharya SK
    Indian J Exp Biol; 1990 Aug; 28(8):742-5. PubMed ID: 2123820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
    Hovevey-Sion D; Kopin IJ; Stull RW; Goldstein DS
    Neuropharmacology; 1989 Aug; 28(8):791-7. PubMed ID: 2506486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
    Rényi L
    Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors.
    Gudelsky GA; Koenig JI; Jackman H; Meltzer HY
    Psychopharmacology (Berl); 1986; 90(3):403-7. PubMed ID: 2947256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoamine oxidase-B inhibitor, MD 780236, metabolized essentially by the A form of the enzyme in the rat.
    Strolin Benedetti M; Dow J
    J Pharm Pharmacol; 1983 Apr; 35(4):238-45. PubMed ID: 6133934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
    Hársing LG; Vizi ES
    Br J Pharmacol; 1984 Nov; 83(3):741-9. PubMed ID: 6439273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.
    Azzaro AJ; King J; Kotzuk J; Schoepp DD; Frost J; Schochet S
    J Neurochem; 1985 Sep; 45(3):949-56. PubMed ID: 3928811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
    Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
    Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
    Kerecsen L; Bunag RD
    J Pharmacol Exp Ther; 1989 Nov; 251(2):645-9. PubMed ID: 2509682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.
    Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
    Neurochem Res; 2005 Nov; 30(11):1377-85. PubMed ID: 16341934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.